- $14.32bn
- $14.63bn
- $34.70bn
- 96
- 49
- 70
- 83
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25,282 | 27,266 | 29,285 | 33,478 | 34,702 |
Cost of Revenue | |||||
Gross Profit | 1,913 | 2,040 | 2,431 | 2,632 | 2,867 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 24,611 | 26,815 | 28,230 | 32,089 | 33,165 |
Operating Profit | 672 | 451 | 1,055 | 1,389 | 1,537 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 451 | 261 | 944 | 1,231 | 1,262 |
Provision for Income Taxes | |||||
Net Income After Taxes | 276 | 56.8 | 698 | 996 | 818 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 287 | 53.9 | 696 | 996 | 818 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 287 | 53.9 | 696 | 996 | 818 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.16 | 2.02 | 5 | 7.24 | 5.2 |
Dividends per Share |